XML 188 R51.htm IDEA: XBRL DOCUMENT

Related Parties (Tables)

12 Months Ended

Dec. 31, 2019

The balances and transactions between the Company and its subsidiaries with other related parties are disclosed below:


	Loans
	Assets		Liabilities
Química da Bahia Indústria e Comércio S.A.		0		2,875
Others		490		1,050

Total as of December 31, 2019		490		3,925


	Loans
	Assets		Liabilities
Química da Bahia Indústria e Comércio S.A.		—		2,925
Others		490		1,146

Total as of December 31, 2018		490		4,071

Loans agreements have indeterminate terms and do not contain interest clauses.


	Commercial transactions
	Receivables (1)		Payables (1)		Sales and services		Purchases		Expenses
Oxicap Indústria de Gases Ltda.		0		1,545		1		18,565		0
Refinaria de Petróleo Riograndense S.A.		0		264,602		0		1,019,108		0
ConectCar Soluções de Mobilidade Eletrônica S.A.		739		113		7,385		121		0
LA’7 Participações e Empreend. Imob. Ltda. (a)		0		124		0		0		1,477
Chevron Latin America Marketing LLC		0		0		0		0		0

Total as of December 31, 2019		739		266,384		7,386		1,037,794		1,477


	Commercial transactions
	Receivables (1)		Payables (1)		Sales and services		Purchases		Expenses
Oxicap Indústria de Gases Ltda.		—		567		6		9,032		—
Refinaria de Petróleo Riograndense S.A.		—		24,630		—		1,008,860		—
ConectCar Soluções de Mobilidade Eletrônica S.A.		1,042		136		3,844		186		—
LA’7 Participações e Empreend. Imob. Ltda. (a)		—		117		—		—		1,469

Total as of December 31, 2018		1,042		25,450		3,850		1,018,078		1,469


	Commercial transactions
	Receivables (1)		Payables (1)		Sales and services		Purchases		Expenses
Oxicap Indústria de Gases Ltda.		—		1,489		6		18,108		—
Refinaria de Petróleo Riograndense S.A.		—		22,199		—		1,004,030		—
ConectCar Soluções de Mobilidade Eletrônica S.A.		1,067		31		7,239		859		—
LA’7 Participações e Empreend. Imob. Ltda. (a)		—		125		—		—		2,300

Total as of December 31, 2017		1,067		23,844		7,245		1,022,997		2,300

(1)	Included in “domestic trade receivables”, “domestic trade payables” and “domestic trade payables—reverse factoring”, respectively.

(a)	Refers to rental contracts of 15 drugstores owned by LA’7 as of December 31, 2019 and 2018, a company of the former shareholders of Extrafarma that are current shareholders of Ultrapar.

The expenses for compensation of its key executives (Company’s directors and executive officers) as shown below:

The table below summarizes shares granted to the Company and its subsidiaries’ management:


Grant date	Balance of number of shares granted		Vesting period		Market price of shares on the grant date (in R$ per share)		Total grant costs, including taxes		Accumulated recognized grant costs			Accumulated unrecognized grant costs
March 13, 2017		200,000		2022 to 2024		34.00		9,378		(4,513	)		4,865
March 4, 2016		380,000		2021 to 2023		32.72		17,147		(11,164	)		5,983
December 10, 2014		533,324		2019 to 2021		25.32		27,939		(23,967	)		3,972
March 5, 2014		111,200		2020 to 2021		26.08		5,999		(5,610	)		389
November 7, 2012		—		2019		21.45		16,139		(16,139	)		—

		1,224,524						76,602		(61,393	)		15,209

The table below summarizes the changes of number of shares granted:


Balance on December 31, 2017	2,366,796
Cancellation of granted shares due to termination of executive employment	(433,332	)
Shares vested and transferred	(233,336	)

Balance on December 31, 2018	1,700,128
Shares vested and transferred	(475,604	)

Balance on December 31, 2019	1,224,524

The table below summarizes the restricted and performance stock programs:


Program	Grant date	Balance of number of shares granted		Vesting period		Market price of shares on the grant date (in R$ per share)		Total grant costs, including taxes		Accumulated recognized grant costs			Accumulated unrecognized grant costs
Restricted	October 1, 2017		240,000		2023		38.19		12,642		(4,741	)		7,901
Restricted and performance	November 8, 2017		75,876		2020 to 2022		38.19		5,014		(2,850	)		2,164
Restricted and performance	April 4, 2018		184,076		2021 to 2023		34.35		12,066		(5,539	)		6,527
Restricted	September 19, 2018		160,000		2024		19.58		4,321		(900	)		3,421
Restricted	September 24, 2018		80,000		2024		18.40		2,030		(423	)		1,607
Restricted and performance	April 3, 2019		558,708		2022 to 2024		23.25		24,096		(4,729	)		19,367
Restricted	September 2, 2019		440,000		2025		16.42		10,074		(560	)		9,514

			1,738,660						70,243		(19,742	)		50,501


Balance on December 31, 2017	332,540
Shares granted on April 9, 2018	207,184
Shares granted on September 19, 2018	160,000
Shares granted on September 24, 2018	80,000
Cancellation of granted shares due to termination of executive employment	(39,772	)

Balance on December 31, 2018	739,952
Shares granted on April, 3, 2019	567,876
Shares granted on September 2, 2019	440,000
Cancellation of granted shares due to termination of executive employment	(9,168	)

Balance on December 31, 2019	1,738,660